Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Large amounts of neopterin are produced by interferon-(IFN)-gamma-stimulated human monocytes/macrophages, and increased neopterin concentrations indicate cellular immune activation. In parallel, IFN-gamma induces indoleamine 2,3-dioxygenase which degrades 1-tryptophan to kynurenine. Increased tryptophan degradation rates are indicated by an increased kynurenine/tryptophan ratio (kyn/trp-ratio), reflecting immune system activation, too. In 22 patients with Parkinson's disease (PD) and in 11 age-matched controls, serum and cerebrospinal fluid (CSF) neopterin concentrations were measured by ELISA. Tryptophan and kynurenine concentrations were determined by HPLC. Neopterin concentrations and kyn/trp-ratios were increased both in serum and CSF of patients as compared to controls. Serum tryptophan was lower in patients. Patients with the highest disease activity presented with highest degree of immune activation. Significant correlations existed between neopterin concentrations and kyn/trp-ratios in serum and CSF. Increased formation of neopterin and enhanced degradation of tryptophan suggest activated cell-mediated immune response in a subgroup of patients with advanced Parkinson's disease.
Widner
B
B
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Austria.
Leblhuber
F
F
Fuchs
D
D
D000368:Aged; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007737:Kynurenine / Q000097:blood* / Q000134:cerebrospinal fluid*; D008297:Male; D019798:Neopterin / Q000097:blood* / Q000134:cerebrospinal fluid*; D010300:Parkinson Disease / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000276:immunology; D014364:Tryptophan / Q000097:blood* / Q000134:cerebrospinal fluid*
D007737:Kynurenine; D019798:Neopterin; D014364:Tryptophan